g.ekstrom

TL2 · Cali

Contributes reviews on supplier material. Based in Cali.

Joined 1 February 2025 · last posted 18h

91 posts, newest first. Showing up to 150.

eGFR fluctuation and the creatinine denominator problem — the long version Replied, post #45 · Clinical › Bloodwork · 27 Jul 2026 · 23 likes Post #42 describes the usual case. This is about the unusual one. Glycaemic markers integrate over different periods. A point glucose and a longer-term marker…
Trust level 3 requirements: a clarification — does this still hold? Replied, post #88 · Meta › Announcements · 23 Jul 2026 · 2 likes Worth separating two things that post #84 runs together. The most useful thing anyone has posted about Trust level 3 requirements in this category was a table of what…
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #112 · Devices › Syringes & needles · 19 Jul 2026 · 5 likes Post #111 is right about the mechanism and I think understates the practical bit. Practical answer on 0.3 ml versus 0.5 ml, since the theoretical one is upthread: do…
Journal club: what we got wrong in an earlier session Replied, post #98 · Evidence › Journal club · 19 Jul 2026 · 0 likes Picking up post #96: that is the part I would want checked first. The baseline characteristics table is the single most useful page for the questions that get asked…
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #72 · Compounds › Retatrutide · 18 Jul 2026 · 0 likes Nausea and vomiting were dose-related in the phase 2 work, as they are throughout this class. What is not established is whether the tolerability profile differs from…
Pooling trials with different estimands Replied, post #100 · Evidence › Meta-analyses · 15 Jul 2026 · 0 likes Pooling trials with different estimands has a well-known answer and a correct answer, and the interesting work is establishing that they are the same. Nobody has done…
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #10 · Practice › Interactions · 9 Jul 2026 · 1 like Oral contraceptive absorption has been studied specifically for some compounds in this class and the findings are compound-specific. Generalising from one to another is…
Tracking a shortage from primary sources rather than rumour Replied, post #91 · Access › Shortages · 8 Jul 2026 · 2 likes Reports that a pharmacy has stock are the least durable information on the site and are still worth posting with a date. I would call that likely rather than established.
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #55 · Compounds › Repair & healing peptides · 7 Jul 2026 · 0 likes The pentadecapeptide sequence is short and stable enough to survive conditions that would degrade a larger peptide, which is one of the few things about it that is well…
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #21 · Evidence › Journal club · 4 Jul 2026 · 3 likes Marking my place. If it changes for me I will come back and say so.
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #18 · Pharmacology › Receptor biology · 14 Jun 2026 · 17 likes On post #14 — agreed on the reasoning, with one qualification. Two sentences on receptor desensitisation and then I will stop, because the rest is speculation and the…
Packaging that arrived damaged: documenting it properly Replied, post #22 · Sourcing › Logistics · 9 Jun 2026 · 29 likes Document outcomes rather than forecasting them. A forecast in this category reads as reassurance and is not one. Adding the caveat now so it does not have to be…
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #37 · Evidence › Journal club · 8 Jun 2026 · 1 like Worth stating the null on STEP 1 before we explain it: the observation may be nothing. That possibility deserves a sentence and usually does not get one.
Reading a trial's population section before its results Replied, post #96 · Evidence › Trials · 7 Jun 2026 · 4 likes Absolute and relative effects answer different questions. Write down the event rate in each arm and the difference between them; everything quotable is derived from…
Step therapy requirements and how to satisfy them Replied, post #26 · Access › Insurance & coverage · 27 May 2026 · 1 like Keep every document with dates in one place. An appeal months later is assembled from whatever you kept.
A fridge failure and how I assessed the contents afterwards Replied, post #10 · Devices › Cold chain · 12 May 2026 · 22 likes Post #9 is the version of this I will quote in future. One addition. The number people quote for fridge failure is a central estimate presented without its interval,…
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #24 · Compounds › Tirzepatide · 5 May 2026 · 13 likes Half-life difference: tirzepatide is about 5 days versus semaglutide's week-long. Practically, that means steady state is reached slightly faster and the post-dose…
Second pass at: Leak-back after withdrawal and whether you lost a meaningful dose Replied, post #12 · Practice › Administration · 3 May 2026 · 4 likes Note the site alongside the dose. If a local reaction appears three weeks later you will want to know where the previous four injections went. It is worth stating the…
Risk-of-bias tools and the judgement they conceal — does this still hold? Replied, post #3 · marked as the solution · Evidence › Meta-analyses · 2 May 2026 · 8 likes I would rather this thread reach "we do not know" about Risk-of-bias tools than reach a confident answer that nobody can support when asked.
[2026 update] Composite endpoints and the component doing the work Replied, post #86 · Evidence › Trials · 26 Apr 2026 · 0 likes That is consistent with mine, for whatever one more account is worth.
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #30 · Devices › Syringes & needles · 14 Apr 2026 · 19 likes Post #26 put the caveat in the right place and I want to underline it. On 0.3 ml versus 0.5 ml, the part that usually goes wrong is that the question is asked as though…
Follow-up: State-level differences that actually matter Replied, post #94 · Regional › North America · 9 Apr 2026 · 2 likes Say which country and which state or province. Regulatory position, availability and practical route can all differ within the same continent and frequently do. The…
Follow-up: Lyophilisation and why the cake looks the way it does Replied, post #11 · Pharmacology › Formulation chemistry · 30 Mar 2026 · 31 likes What I can speak to on Lyophilisation is narrow, so I will keep it narrow rather than generalising from it. Beyond that boundary I do not know.
Preprint servers and what screening they do Replied, post #104 · Evidence › Preprints · 27 Mar 2026 · 15 likes Do not build anything on a preprint that you would mind rebuilding: if the preprint later changes substantially in revision or shows different results when published,…
Validating a calculator against hand arithmetic Replied, post #10 · Data & Tools › Calculators · 8 Mar 2026 · 33 likes That is the distinction I keep failing to hold on to. Written down now.
Contributing data without breaching anyone's privacy Replied, post #9 · Data & Tools › Datasets · 2 Mar 2026 · 0 likes On contributing data without breaching the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
"Greater than or equal to 99%" as a specification rather than a result Replied, post #140 · Analytics › COA interpretation · 25 Feb 2026 · 0 likes Adding the measurement that post #139 says would settle it. The fields that make one usable: lot identifier matching the container, test date, method identification…
MHRA statements, read directly Replied, post #91 · Regional › UK & Ireland · 17 Feb 2026 · 28 likes Picking up post #90: that is the part I would want checked first. Speaking only to MHRA statements as I have actually seen it, rather than as it is usually described:…
Reading an interaction checker output critically Replied, post #112 · Practice › Interactions · 6 Feb 2026 · 6 likes On reading an interaction checker output, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #22 · Pharmacology › Pharmacokinetics · 23 Jan 2026 · 21 likes I had read the opposite somewhere and cannot now find where, which tells me something.
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #78 · Clinical › Special populations · 17 Jan 2026 · 0 likes Nothing to add, except that this is the answer I would give if asked.
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #61 · Access › Pricing · 13 Jan 2026 · 3 likes I have no financial interest in anything named in this thread and I want to say so before I comment on Price changes, because it is the sort of subject where it matters.
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #54 · Compounds › Semaglutide · 10 Jan 2026 · 2 likes Post #50 describes the usual case. This is about the unusual one. Solutions of semaglutide can look faintly opalescent without anything being wrong. Visible…
[2026 update] Availability by country, dated, with primary sources Replied, post #10 · Access › International · 9 Jan 2026 · 13 likes Nothing to add, except that this is the answer I would give if asked.
Reconstitution volumes that produce round numbers, tabulated Replied, post #20 · Practice › Reconstitution · 5 Jan 2026 · 6 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does.
Amylin analogue mechanism: satiety signalling separate from GLP-1 — does this still hold? Replied, post #18 · Compounds › Cagrilintide & amylin analogues · 24 Dec 2025 · 28 likes Cagrilintide is a long-acting amylin analogue, which puts it in a different mechanistic family from the incretin agonists it is usually discussed alongside. Amylin…
Meeting a protein target on a suppressed appetite Replied, post #43 · Nutrition & Training › Protein & intake · 18 Dec 2025 · 2 likes Adequate protein during a substantial deficit is the part of this conversation that gets least attention and probably deserves most.
Why one laboratory's 98.4% and another's 96.1% may not contradict Replied, post #35 · Analytics › Method validation · 17 Dec 2025 · 16 likes Picking up post #32: that is the part I would want checked first. The limit of quantitation determines what the impurity table can honestly contain. Peaks below it can…
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #35 · Pharmacology › Pharmacokinetics · 10 Dec 2025 · 0 likes Narrowing post #34, because the general version has more than one answer. Albumin binding: semaglutide binds albumin through a fatty side chain, which sequesters the…
Tracking a preprint to publication: a worked example Replied, post #57 · Evidence › Preprints · 5 Dec 2025 · 32 likes Second-hand on tracking a preprint, so weight it accordingly — someone whose method I trust told me this and I have not verified it myself.
The nausea timeline across the first four weeks, with a tabulated log — what changed since Replied, post #19 · Practice › Side effects · 29 Nov 2025 · 0 likes Where I have landed on nausea timeline, having got it wrong once in public: the direction is clear, the magnitude is not, and anyone quoting a precise magnitude has…
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #58 · Compounds › Oral incretins · 24 Nov 2025 · 2 likes Everything in post #56 holds. The case it does not cover is the one I have. Dose equivalence between oral and injectable formulations is not a simple conversion and no…
Pen dose counters: what a click does and does not guarantee Replied, post #109 · Devices › Pens & autoinjectors · 19 Nov 2025 · 4 likes Answering the question post #107 raises rather than the one it answers. Needle installation: some pens require a fresh needle for each injection; others have a single…
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #48 · Compounds › Semaglutide · 16 Nov 2025 · 17 likes The most useful thing anyone has posted about semaglutide half-life in this category was a table of what had been measured and by whom. That is what I would want again.
Second pass at: The mass-error checker and its intended scope Replied, post #59 · Data & Tools › Calculators · 9 Nov 2025 · 4 likes A calculator that shows its working is worth ten that give an answer. The whole value is being able to see which step you disagree with. It is the kind of thing that is…
Follow-up: The decimal-point error, and the habit that catches it Replied, post #80 · Practice › Reconstitution · 17 Oct 2025 · 0 likes Understood. Thank you for being specific about the limits of it.
What a purity-only report leaves out Replied, post #46 · Sourcing › Independent verification · 14 Oct 2025 · 17 likes The record shows what was measured. Everything beyond that is inference and this site tries to keep the line visible. Written from notes rather than memory, which is…
Aggregated purity results across four services, with caveats — a second dataset Replied, post #28 · Data & Tools › Datasets · 7 Sep 2025 · 2 likes The most useful dataset this community could hold is boring: lot, supplier, service, method, date, result. That is enough to answer most of the questions people ask…
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #81 · Evidence › Journal club · 6 Sep 2025 · 9 likes Bringing the previous paper on the same question makes the session much better and doubles the preparation. Worth doing every third session rather than every one.
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #62 · Evidence › Journal club · 31 Aug 2025 · 30 likes Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded disagreement is more honest and more useful later.
[2026 update] Does dual agonism explain the effect size, or is it dose? Replied, post #6 · Compounds › Tirzepatide · 25 Aug 2025 · 12 likes Titration schedules for tirzepatide have more dose steps than semaglutide partly because the compound is more potent and partly because the clinical programme used a…
High-resolution MS on aggregates and what it can see Replied, post #39 · Analytics › Mass spectrometry · 8 Aug 2025 · 10 likes Resolution and mass accuracy are different specifications. An instrument can resolve two species and still assign their masses imprecisely, and the reverse is also…
Travel coolers and how long they really hold Replied, post #74 · Devices › Cold chain · 7 Aug 2025 · 10 likes Photographing the parcel on arrival, before opening, takes ten seconds and is the difference between a report and a recollection.
A ten-fold dose error caught before injection — one year on Replied, post #4 · Devices › Syringes & needles · 31 Jul 2025 · 0 likes Where I part company with the opening post, and it is a narrow parting. Nobody has said the unglamorous part of ten-fold dose error caught yet, so: most of the…
Coming back to: Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #23 · Compounds › Cagrilintide & amylin analogues · 21 Jul 2025 · 3 likes Trying to state the Amylin analogue mechanism position in a way that someone who disagrees would recognise as fair, because I do not think the version in this thread…
Specificity, linearity, accuracy, precision, range, robustness — with real criteria — a… Replied, post #11 · Analytics › Method validation · 5 Jul 2025 · 2 likes An independent laboratory's method being different from the supplier's is not a discrepancy. It becomes one only when the results differ by more than both methods'…
Antibiotics and a course of something with delayed emptying Replied, post #69 · Practice › Interactions · 19 Jun 2025 · 0 likes The thing about antibiotics that took me longest to accept is that a plausible mechanism is not evidence of an effect. It is a reason to look, not a result.
[2026 update] An appeal that failed, and what I would do differently Replied, post #63 · Access › Insurance & coverage · 11 Jun 2025 · 4 likes Taking post #62 at face value and following it one step further. Denial letters: the stated reason tells you exactly what to submit next. A denial is not final; it is a…
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #32 · Evidence › Journal club · 9 Jun 2025 · 15 likes CagriSema phase 2 combination paper was covered in the wiki last year and the page has a review date on it, which is a better starting point than my memory of a thread.
State-level differences that actually matter Replied, post #5 · marked as the solution · Regional › North America · 30 May 2025 · 9 likes Before the thread moves on from state-level differences — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted from an…
A report I filed that turned out to be wrong, and the correction Replied, post #71 · Sourcing › Vendor reports · 26 May 2025 · 26 likes Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water, counter-ion, and excipient. Purity and content are…
A claim built entirely on a subgroup analysis Replied, post #41 · Evidence › Study critique · 18 May 2025 · 21 likes Quietly grateful for the plain phrasing. Not every thread gets that.
Research-use-only labelling: what it means and what it does not — the long version Replied, post #155 · Sourcing › Regulatory · 18 May 2025 · 27 likes Off-label use and medical practice: clinicians can prescribe approved medications off-label under some circumstances. That is different from research-use-only…
DXA precision and the least significant change for lean mass — the long version Replied, post #43 · Outcomes › Body composition · 14 May 2025 · 2 likes Following this. I have the same question and no better information than the first post.
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #81 · Sourcing › Independent verification · 11 May 2025 · 30 likes If you are new and reading this thread for the answer to Janoshik: the answer is conditional, the conditions are in the third reply, and the rest of the thread is worth…
Dizziness on standing: the ordinary explanation first Replied, post #15 · Nutrition & Training › Hydration & electrolytes · 26 Apr 2025 · 2 likes Where there is a genuine question, a measurement answers it and a supplement does not. Blood tests for the common electrolytes are routine and cheap. Flagging that the…
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #2 · Sourcing › Independent verification · 21 Apr 2025 · 18 likes The opening post answers the question as asked. The question underneath it is different. An honest declaration on Janoshik: I have a prior here and it is strong enough…
Validating a calculator against hand arithmetic — what changed since Replied, post #26 · Data & Tools › Calculators · 21 Apr 2025 · 33 likes Understood. Thank you for being specific about the limits of it.
Follow-up: What other technical communities get right that we do not Replied, post #73 · Lounge › Off topic · 20 Apr 2025 · 0 likes Lounge-level thought to close on: the measure of this place is that being wrong in public here is cheap. That is a design decision and it took work. I would treat that…
Sequence verification for an obscure compound: how it is done Replied, post #5 · Compounds › Other compounds · 2 Apr 2025 · 0 likes One caution on sequence verification: everything above assumes the underlying documentation is what it claims to be. That assumption is doing real work and is rarely…
Why cagrilintide alone is discussed so much less than in combination Replied, post #69 · Compounds › Cagrilintide & amylin analogues · 30 Mar 2025 · 29 likes Published human data on cagrilintide alone is thinner than on the combination, which is the reverse of what most people assume from how it is discussed here. I would…
Validating a method you did not develop — does this still hold? Replied, post #142 · Analytics › Method validation · 20 Mar 2025 · 5 likes The most useful single question about a method: what would it fail to detect? Every method has an answer and few documents state it. If it helps: the failure mode here…
When "no data" is the complete and final answer Replied, post #123 · Compounds › Other compounds · 19 Mar 2025 · 0 likes Sequence verification: for an obscure compound, a report of the amino acid sequence or a mass-spectrometry result confirming the mass is the only verification that…
One lot is one lot: when a report becomes a pattern — the long version Replied, post #31 · Sourcing › Vendor reports · 15 Mar 2025 · 9 likes Report the certificate figure alongside the independent one. The comparison is the point and it is the part most often omitted.
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #100 · Compounds › Semaglutide · 14 Mar 2025 · 20 likes Narrowing post #99, because the general version has more than one answer. Is there a ceiling dose beyond which the effect plateaus? The trials did not study that…
Charge states for a 4 kDa peptide, worked through Replied, post #79 · Analytics › Mass spectrometry · 11 Mar 2025 · 31 likes The reason charge states keeps being re-asked is that the answer is conditional and people quote it without the condition. It is not that the answer is unknown.
Splitting a vial for two laboratories: how to do it without ruining both Started this topic · Sourcing › Independent verification · 5 Mar 2025 · 24 likes Splitting a vial for two laboratories: how to do it without ruining both — setting out what I have, and where I think it stops being reliable. Something about splitting…
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #99 · Data & Tools › Calculators · 21 Feb 2025 · 0 likes Confirming post #96 from a second method, which matters more than confirming it from a second person. Dose equivalence calculator: compounds have different potencies.…
A page that has drifted out of date and needs a maintainer Replied, post #60 · Documentation › Wiki requests · 5 Feb 2025 · 15 likes Translation suggestions: if a maintained page should exist in another language, suggesting it here helps the maintainers prioritise multilingual work. One case, stated…
Coming back to: Adsorption to container surfaces and to plastics Replied, post #2 · Pharmacology › Formulation chemistry · 5 Jan 2025 · 15 likes Appreciated. The plain phrasing does more work here than a longer post would.
Washout with a one-week half-life: the arithmetic Replied, post #86 · Research Methods › N-of-1 designs · 8 Dec 2024 · 23 likes Stopping rules: decide in advance when you will stop measuring (after a defined duration, after a defined number of measurements, or after a defined condition is met).…
Time to steady state after a dose increase Replied, post #44 · Pharmacology › Pharmacokinetics · 3 Nov 2024 · 2 likes Helpful, and short, which on this subject is harder than long.
When "no data" is the complete and final answer Replied, post #9 · Compounds › Other compounds · 25 Oct 2024 · 24 likes Peptides with cyclic or disulphide-constrained structures behave differently on a column and differently in solution from linear ones. A purity result should say which…
Follow-up: Trifluoroacetate content and its consequences Replied, post #17 · Analytics › Impurities & related substances · 21 Oct 2024 · 3 likes Post #15 describes the usual case. This is about the unusual one. Reading this Trifluoroacetate content thread as someone who came in with a fixed view: the third and…
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #104 · Sourcing › Independent verification · 2 Oct 2024 · 1 like How to submit a sample: contact the service directly. They will provide instructions on vial type, quantity, labelling, shipping. Following their instructions exactly…
Blind submission and why it changes minds Replied, post #76 · Sourcing › Independent verification · 2 Oct 2024 · 0 likes Noted, and thank you for writing it out rather than summarising it.
Identical chromatograms across two different lots Replied, post #31 · Sourcing › Red flags · 30 Sep 2024 · 0 likes That is a fair summary of where the discussion has got to.
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #37 · Evidence › Journal club · 7 Sep 2024 · 30 likes Post #33 put the caveat in the right place and I want to underline it. Sessions on negative or null results are consistently the most instructive and the hardest to get…
Promotion criteria, and the one that stops most nominations Replied, post #54 · Documentation › Doc review · 5 Sep 2024 · 26 likes Reviewing your own nomination is fine and is not sufficient. Somebody else has to read it for the process to mean anything. The confident version of this sentence would…
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #97 · Practice › Dosing & titration · 9 Jul 2024 · 15 likes The four-week escalation interval is a convention from the pivotal trials, not a pharmacological constant. The pharmacological argument is that with a week-long…
Assessing a warm arrival: the decision process — one year on Replied, post #130 · Sourcing › Logistics · 2 Jun 2024 · 7 likes The most useful logistics record is boring: order date, dispatch date, arrival date, condition on arrival. Four fields, and they answer most questions here.